Medical Strategy - Biotech Investors jobs and careers

About Medical Strategy - Biotech Investors

Within the scope of our core competence, we focuse exclusively on the management and advisory of equity portfolios in the healthcare/biotech sector. **Objective** Our primary goal is to identify innovations in the healthcare sector at an early stage - in order to generate above-average long-term results for investors by investing in low-rated growth companies. In our inhouse database, we systematically document and analyze over 900 companies from the international healthcare sector. This information base is constantly being expanded through in-house and external specialized research. **Flexibility** All segments of the healthcare sector are open to us for our investment decisions. In doing so, we do not orientate ourselves to the standardized benchmarks. Rather, we make targeted investments in companies that are not threatened by a drop in sales, but which show a high dynamic for value enhancement through innovative strength. **Experience and deep understanding** The team of Medical Strategy is made up of experts with complementary backgrounds and decades experience in both the health and financial sectors together. This results in a profound understanding of the scientific and investment relevant developments in the healthcare market. We continuously analyze listed companies in all relevant segments of the healthcare sector. **Independence - Supervision** As an owner-managed company, we are completely independent in our decisions. Since 2002 Medical Strategy has been a member of the Association of Independent Asset Managers (VuV). Already since 1998 the company has been licensed for financial portfolio management by the Federal Financial Supervisory Authority (BaFin).